The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo

Drug delivery nanocarriers, especially targeted drug delivery by liposomes are emerging as a class of therapeutics for cancer. Early research results suggest that liposomal therapeutics enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localizat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Huei Leng Helena, Lu, Aiping, Lin, Ge, Qin, Ling, Yang, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307245/
https://www.ncbi.nlm.nih.gov/pubmed/25547490
http://dx.doi.org/10.3390/ijms16010230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307245/
https://www.ncbi.nlm.nih.gov/pubmed/25547490
http://dx.doi.org/10.3390/ijms16010230

Ejemplares similares